Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

The women’s health field has a long way to go addressing persistent deficits in research and treatment. Common conditions that affect women like endometriosis and polycystic ovarian syndrome remain ...

Neal Goldman, Chairman and Interim CEO of Milestone Scientific, commented: ...

Tower Research Capital LLC TRC trimmed its stake in Nevro Corp. (NYSE:NVRO – Free Report) by 59.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...

His previous board service includes Nevro Corp., which was acquired by Globus Medical, Inc. in April 2025, and GenMark Diagnostics, which was taken over by Roche in May 2021. O’Boyle also has ...

Mr. O’Boyle served on the board of directors of Nevro Corp. from March 2019 through April 2025 when the company was acquired by Globus Medical, Inc. He also served as Chairman of the GenMark ...

Scavilla confirmed the acquisition of Nevro Corporation for $250 million, expanding Globus Medical's reach into the musculoskeletal market, particularly in neuromodulation technology and chronic ...

The acquisition of Nevro Corporation is seen as a strategic move to expand into a $3 billion market space, enhancing Globus Medical Inc (NYSE:GMED)'s reach in the musculoskeletal market.

We returned to debt free status in Q1, paying off the remainder of the nearly $900 million debt inherited from the NuVasive merger and generating enough cash to pay for the Q2 Nevro acquisition ...